|
Market Closed -
Japan Exchange
02:30:00 2026-08-24 EDT
|
5-day change | 1st Jan Change | ||
| 2,444.00 JPY | -0.16% |
|
+0.58% | +12.50% |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| 07-30 | Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1,148B 7.22B 6.19B 5.79B 5.29B 9.99B 691B 10.09B 68.49B 26.63B 347B 27.11B 26.52B | P/E 2027 * |
15.4x | P/E 2028 * | 17.7x |
|---|---|---|---|---|---|
| Enterprise Value | 947B 5.96B 5.1B 4.77B 4.36B 8.24B 570B 8.32B 56.5B 21.97B 286B 22.36B 21.88B | EV / Sales 2027 * |
2.07x | EV / Sales 2028 * | 2.01x |
| Free-Float |
80.98% | Yield 2027 * |
3.21% | Yield 2028 * | 3.17% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | -0.16% | ||
| 1 week | +0.58% | ||
| Current month | +2.52% | ||
| 1 month | +1.90% | ||
| 3 months | -1.55% | ||
| 6 months | -6.63% | ||
| Current year | +12.50% |
| 1 week | 2,396 |  | 2,499 |
| 1 month | 2,264.5 | | 2,514.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.16% | +0.58% | +47.14% | -11.83% | 7.24B | |
| +0.40% | -1.04% | +16.34% | +69.97% | 47.71B | |
| +0.12% | +1.50% | +51.38% | +122.20% | 40.3B | |
| +0.40% | -0.83% | -9.73% | +16.84% | 12.09B | |
| -1.45% | -2.77% | +11.63% | +71.04% | 11.68B | |
| +0.19% | +0.58% | +30.98% | +158.71% | 9.19B | |
| +3.49% | +2.54% | +25.87% | +46.08% | 7.57B | |
| +3.14% | +3.12% | +23.40% | +215.25% | 6.84B | |
| -3.24% | -9.40% | -40.05% | +18.52% | 5.42B | |
| -1.65% | -2.53% | +35.68% | +102.63% | 4.75B | |
| Average | +0.09% | -1.30% | +19.27% | +80.94% | 15.28B | |
| Weighted average by Cap. | +0.21% | -0.66% | +24.89% | +85.60% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 457B 2.88B 2.46B 2.31B 2.11B 3.98B 275B 4.02B 27.28B 10.61B 138B 10.8B 10.56B | 448B 2.81B 2.41B 2.26B 2.06B 3.89B 269B 3.93B 26.69B 10.38B 135B 10.56B 10.34B |
| Net income | 74.65B 469M 402M 376M 344M 649M 44.93B 656M 4.45B 1.73B 22.56B 1.76B 1.72B | 64.78B 407M 349M 326M 298M 563M 38.99B 569M 3.86B 1.5B 19.58B 1.53B 1.5B |
| Net Debt | -201B -1.26B -1.08B -1.01B -927M -1.75B -121B -1.77B -11.99B -4.66B -60.78B -4.75B -4.64B | -250B -1.57B -1.35B -1.26B -1.15B -2.17B -150B -2.19B -14.89B -5.79B -75.47B -5.89B -5.77B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-24 | JP¥2,444.00 | -0.16% | 1,189,600 |
| 26-08-21 | JP¥2,448.00 | -1.35% | 1,467,200 |
| 26-08-20 | JP¥2,481.50 | +0.87% | 1,548,800 |
| 26-08-19 | JP¥2,460.00 | +0.80% | 1,595,900 |
| 26-08-18 | JP¥2,440.50 | +1.33% | 1,426,700 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
